AMPK-p53 function is impaired in T cells of RA patients, which potentially explaining the enhanced mTOR activity, decreased fatty acid oxidation, and increased fatty acid synthesis observed in RA T cells (64, 70). This evidence concerns the gene TP53 and rheumatoid arthritis.